Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CONDUIT PHARMACEUTICALS INC. | Director | Stock Option (Right to Buy) | 65K | $358K | $5.51 | Dec 1, 2023 | Direct |
CONDUIT PHARMACEUTICALS INC. | Director | Warrants | 15K | $173K | $11.50 | Sep 22, 2023 | Direct |
CONDUIT PHARMACEUTICALS INC. | Director | Warrant (Right to buy) | 203K | Apr 22, 2024 | Direct | ||
CONDUIT PHARMACEUTICALS INC. | Director | Common Stock | 52.3K | Jun 11, 2024 | Direct | ||
CONDUIT PHARMACEUTICALS INC. | Director | Common Stock, par value $0.0001 per share ("Shares") | 15K | Sep 22, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CDT | CONDUIT PHARMACEUTICALS INC. | Jun 11, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
CDT | CONDUIT PHARMACEUTICALS INC. | Apr 22, 2024 | 2 | $0 | 4 | Apr 24, 2024 | Director |
CDT | CONDUIT PHARMACEUTICALS INC. | Dec 1, 2023 | 1 | $358K | 4 | Dec 5, 2023 | Director |
MURF | CONDUIT PHARMACEUTICALS INC. | Sep 22, 2023 | 2 | $173K | 4 | Sep 26, 2023 | Director |
MURF | Murphy Canyon Acquisition Corp. | Feb 2, 2022 | 0 | $0 | 3 | Feb 11, 2022 | Director |